Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ND0801 in adult ADHD
NCT01174355Phase 2Completed
- Sponsor
- NeuroDerm Ltd.
- Start
- Oct 2010
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ND0801 in attention deficit hyperactivity disorder (ADHD), sponsored by NeuroDerm Ltd.. Started Oct 2010; status: completed.
02
Drugs
ND0801
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01174355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174355.